What facilitators and service centers can say about outcomes

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

For licensed psilocybin facilitators, service centers, and their marketing staff who want to understand precisely what claims about client outcomes, experiences, and results are permissible — and what crosses into prohibited territory under OPS rules and FTC standards.

The short answer

Outcome claims are the category of marketing statement most likely to create regulatory and legal exposure for a psilocybin service center. Oregon’s OPS rules prohibit claims that psilocybin services treat or manage health conditions. The FTC requires that any objective claim about what clients can expect from services be substantiated by competent and reliable evidence. And the inherent variability of psilocybin experiences — ranging from profound and meaningful to neutral to deeply challenging — makes any specific outcome claim difficult to substantiate for a general client population at a specific service center. The permissible space for outcome claims is not zero, but it is narrower than most service centers’ initial marketing instincts would suggest. What is permissible is accurate description of what the service involves, honest characterization of the range of experiences, and qualified references to what the broader research suggests — not promises about what any individual client will experience.

The OPS prohibition on health outcome claims

OAR 333-333-6040 prohibits service centers and facilitators from representing that psilocybin services treat, cure, manage, or have demonstrated clinical efficacy for any health condition. This prohibition covers both direct claims (“our sessions treat depression”) and implied claims that convey the same meaning without using those exact words.

A service center whose homepage is structured to suggest that booking a session is the path to recovery from depression — through a combination of research statistics, client testimonials about overcoming depression, and a call-to-action for depressed individuals — may be making an implied health outcome claim even if no individual sentence says “we treat depression.” The overall impression that a reasonable prospective client would receive from the marketing is the relevant standard, not whether each sentence passes a literal reading.

The prohibition is not limited to depression. It covers any health condition — PTSD, anxiety, addiction, chronic pain, end-of-life distress, eating disorders, OCD, or any other condition for which a client might seek psilocybin services. A service center that markets specifically to veterans with PTSD with language implying that the program addresses PTSD symptoms is making a health outcome claim that OPS rules prohibit regardless of what the research on psilocybin for PTSD suggests.

What can be said about client experiences

The prohibition on health outcome claims does not prevent service centers from describing what clients commonly experience during and after psilocybin sessions in honest, non-medical terms. There is a meaningful distinction between:

“Our sessions treat PTSD and depression.” (Prohibited — health outcome claim)

“Many clients describe their sessions as emotionally meaningful, challenging, and sometimes profoundly clarifying. Experiences vary significantly between individuals.” (Permissible — honest description of experiential range)

“Research suggests psilocybin may have potential for certain mental health conditions, though this research was conducted in controlled clinical trial settings that differ from Oregon’s licensed facilitation program.” (Permissible — qualified reference to research with appropriate disclaimer)

“Clients often report a sense of increased openness and psychological flexibility in the weeks following a session.” (Potentially permissible if accurate and qualified, but approaches the boundary — should be reviewed)

The line between describing what clients commonly experience and claiming that services produce specific psychological or health outcomes is not always obvious. The governing principle is whether the claim, as a reasonable prospective client would understand it, implies a guaranteed or predictable health outcome. If it does, it is prohibited or requires FTC-level substantiation that a service center typically cannot provide for its own client population.

Variability disclosure

One of the most important — and most frequently omitted — elements of honest outcome communication for psilocybin services is disclosure of variability. Psilocybin experiences vary enormously between individuals. Factors including set, setting, dose, medication history, psychological history, and the quality of the facilitation all affect outcomes. Some clients have experiences they describe as profoundly positive. Some have experiences that are challenging or distressing. Some have experiences that feel neutral or underwhelming.

A service center that presents only glowing outcome descriptions — whether in marketing copy or through carefully curated testimonials — without any acknowledgment of this variability is presenting a misleading picture of what prospective clients can expect. FTC standards require that testimonials reflect typical results or that marketing materials disclose what typical results look like. Honest variability disclosure is both a regulatory compliance element and a client welfare consideration — a client who enters a session with unrealistic expectations shaped by one-sided marketing is at greater risk of a difficult experience than one who has been honestly informed.

Referencing the research

Service centers frequently want to reference the scientific research on psilocybin’s potential — the Phase 3 trial data for treatment-resistant depression, the Johns Hopkins studies on end-of-life distress, the tobacco cessation and alcohol use disorder research. This is a legitimate and informative thing to do, but how it is done determines whether it complies with OPS rules and FTC standards.

Permissible: “Research published in peer-reviewed journals, including Phase 3 clinical trials, has demonstrated statistically significant reductions in depression symptoms for psilocybin in controlled research settings. These findings are from clinical trials with specific protocols and participant populations; Oregon’s licensed program operates in a wellness facilitation model that differs from the controlled clinical trial setting.”

Problematic: “Clinical trials prove that psilocybin cures depression. Book your session today.”

The key distinction is between accurately describing what research has found, with appropriate qualification about what that research involved and what it means for the service center’s specific program, versus using research findings as if they are a warranty for what the service center’s sessions will produce.

A service center should not reproduce specific statistics from research papers in marketing materials without the full context that makes those statistics meaningful — particularly the fact that trial results reflect outcomes in controlled conditions that may not translate directly to a different service model.

Describing facilitator experience and specialization

A service center or facilitator can describe the populations or contexts in which the facilitator has experience — veterans, end-of-life clients, individuals with grief or loss, clients seeking personal growth — without making outcome claims about those populations. The description of experience is factual; the implication that the experience guarantees better outcomes for those populations would be a claim that requires substantiation.

A facilitator who says “I have experience working with clients navigating grief and loss” is making a factual statement about their background. A facilitator who says “my sessions reliably help clients resolve grief” is making an outcome claim that is difficult to substantiate and likely implies a therapeutic benefit that OPS rules prohibit representing.

Program completion and return rates

A service center that wants to share statistics about client satisfaction — the percentage of clients who complete their session sequences, the percentage who report the experience as valuable, the percentage who return for subsequent sessions — is sharing data that is factual and potentially useful to prospective clients, provided the data is real and accurately represented.

These statistics are not health outcome claims — they are measures of client experience and engagement. They are permissible if accurate, and they should be presented with enough context that a prospective client can evaluate what they mean. “92% of our clients report feeling the session was worth the cost” says something meaningful about client satisfaction without implying a health outcome.

What facilitators say in intake conversations

The outcome claim prohibitions are not limited to written marketing. A facilitator who, during an intake or preparation session, tells a client that the session will cure their depression, that they are guaranteed to have a profound experience, or that psilocybin works better than antidepressants has made a prohibited claim in a non-marketing context. OAR 333-333-6040 applies to representations made about psilocybin services — not just to advertising copy.

Facilitator training and service center staff training should address what can and cannot be said in direct client conversations, not just in published marketing materials.

When public information may be enough

OAR 333-333-6040 is available through the Oregon Secretary of State’s administrative rules database. The FTC’s guidance on health claims substantiation and endorsements is at ftc.gov. OPS has published FAQ guidance on marketing compliance at oregon.gov/psilocybin.

When you should speak with a lawyer

A service center that has developed detailed outcome-oriented marketing materials — particularly those that reference research statistics, feature extensive client testimonials, or target specific health populations — should have those materials reviewed by an attorney familiar with both OPS marketing rules and FTC advertising standards before publishing. A service center that has received a complaint from a client alleging that marketing representations about outcomes were misleading should retain counsel before responding to the complaint or to OPS.

You might also want to read

• What psychedelic businesses can and cannot say in marketing
• Why calling it therapy is a legal problem in Oregon
• Health claims, testimonials, and FTC rules for psychedelic services
• Pricing transparency and fee disclosure requirements
• Press, media, and public communications for psychedelic businesses